Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
NIH established Centers for Research in Emerging Infectious Diseases
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
RedHill Biopharma Announced Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
Biotechnology | COVID-19 | Diagnostics | NIH
White House announced plan to deploy 150 million rapid tests in 2020
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
Assembly Biosciences and Arbutus announced collaboration to evaluate combination of core inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in patients with Chronic Hepatitis B Virus Infection
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
Rapid diagnostic detected Lassa and Ebola in real-time
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
How SARS-CoV-2 spread across greater Boston during pandemic’s first wave
On Aug. 25, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, the Massachusetts…
CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
Momentous milestone as Africa announced eradication of wild Poliovirus
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…
University of Oxford study described which cancer patients are more vulnerable to COVID-19
On Aug. 24, 2020, a published study led by the Universities of Oxford and Birmingham found that, compared…
Novavax initiated phase 2 portion of phase 1/2 clinical trial of COVID-19 vaccine
On Aug. 24, 2020, Novavax announced that the first volunteers were enrolled in the Phase 2 portion of…
AXIM Biotechnologies signed exclusive licensing, manufacturing and distribution agreement for production of COVID-19 rapid neutralizing antibody test
On Aug. 24, 2020, AXIM Biotechnologies announced that it had signed an exclusive limited licensing, manufacturing and distribution…
Biotechnology | COVID-19 | FDA | Therapeutics
XBiotech announced COVID-19 candidate therapy
On Aug. 24, 2020, XBiotech announced that the U.S. Food and Drug Administration (FDA) issued an emergency use…
Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility
On Aug. 23, 2020, the World Heath Organization (WHO) reported that 172 economies were engaged in discussions to…
Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
Biotechnology | COVID-19 | Disease | Medicine | NIH | Therapeutics
La Jolla Institute for Immunology awarded $6.4 million for international efforts to beat COVID-19
On Aug. 20, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes…
Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
Quidel update point-of-care Sofia SARS Antigen Test for COVID-19 to include either nasal or nasopharyngeal swabs
On Aug. 19, 2020, Quidel announced that labeling for Quidel’s Emergency Use Authorization (EUA) for the Sofiaﾮ SARS…
Experimental COVID-19 vaccine prevented severe disease in mice
On Aug. 19, 2020, an experimental vaccine was reported to be effective at preventing pneumonia in mice infected…
UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…
Sanofi acquired Principia Biopharma for $3.68 billion
On Aug. 17, 2020, Sanofi and Principia Biopharma announced a definitive agreement under which Sanofi will acquire all…
XBiotech announced COVID-19 candidate therapy
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
Atossa Therapeutics announced enrollment and dosing completed in clinical study of AT-301 COVID-19 nasal spray
On Aug. 17, 2020, Atossa Therapeutics announced that it had enrolled and dosed the first cohort of healthy…
Costa Rica announced horse antibodies for trials as an inexpensive COVID-19 therapy
On Aug. 17, 2020, Scientisfic American reported that Costa Rican scientists at the Clodomiro Picado Institute have inoculated…
FDA approved teatment for rare disease affecting optic nerves, spinal cord
On Aug. 17, 2020, the U.S. Food and Drug Administration (FDA) approved Genentech’s Enspryng (satralizumab-mwge) for the treatment…